Category: Health
Checks reveal young women with deadly ‘silent’ heart risk
Source link : https://newshealth.biz/health-news/checks-reveal-young-women-with-deadly-silent-heart-risk/ Sudden cardiac death can happen without warning, and it’s not just a problem for sporty young men, say experts. Source link : https://www.bbc.com/news/articles/c1l218n82pdo?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-31 23:21:00 Copyright for syndicated content belongs to the linked Source. The post Checks reveal young women with deadly ‘silent’ heart risk first…
Practice-Changing Trial in Prostate Cancer Shows Benefits of Perioperative Therapy
Source link : https://newshealth.biz/health-news/practice-changing-trial-in-prostate-cancer-shows-benefits-of-perioperative-therapy/ CHICAGO — A paradigm-changing clinical trial in prostate cancer showed that perioperative apalutamide (Erleada) and androgen deprivation therapy (ADT) significantly reduced the risk of metastasis in high-risk localized disease versus ADT alone. After more than 5 years of follow-up, metastasis-free survival (MFS) improved from 73.5% with ADT alone to 78.2% with…
Teclistamab Alone Ups Previously Treated Myeloma Survival
Source link : https://newshealth.biz/health-news/teclistamab-alone-ups-previously-treated-myeloma-survival/ In the first phase 3 trial of teclistamab monotherapy, the bispecific antibody was associated with better PFS and OS than standard regimens in relapsed or refractory multiple myeloma. Medscape Medical News Source link : https://www.medscape.com/viewarticle/teclistamab-alone-ups-previously-treated-myeloma-survival-2026a1000i2u?src=rss Author : Publish date : 2026-05-31 21:55:00 Copyright for syndicated content belongs to the linked Source.…
Upfront Ivonescimab Plus Chemo Bests PD-1 Inhibitor Combo in Advanced NSCLC
Source link : https://newshealth.biz/health-news/upfront-ivonescimab-plus-chemo-bests-pd-1-inhibitor-combo-in-advanced-nsclc/ CHICAGO — A first-in-class bispecific antibody targeting PD-1 and VEGF combined with chemotherapy significantly improved overall survival (OS) in patients with advanced squamous non-small cell lung cancer (NSCLC), according to the HARMONi-6 trial. At a median follow-up of 21.4 months, the ivonescimab-chemotherapy combination in the first line reduced the risk of…
‘The Light Goes Out of Their Eyes in About 3 Years’: What We Heard This Week
Source link : https://newshealth.biz/health-news/the-light-goes-out-of-their-eyes-in-about-3-years-what-we-heard-this-week/ “The light goes out of their eyes in about 3 years. This is not what they signed up for.” — Clark Coler, MD, of Swedish Medical Group in Seattle, on young physicians facing the increasingly profit-driven demands of modern healthcare. “They feel relief, not pleasure, not joy, just relief.” — Daniel…
Abemaciclib Poised to Be New Standard of Care in Aggressive Liposarcoma
Source link : https://newshealth.biz/health-news/abemaciclib-poised-to-be-new-standard-of-care-in-aggressive-liposarcoma/ CHICAGO — Treatment with the CDK4/6 inhibitor abemaciclib (Verzenio) offered a dramatic survival uptick in a highly aggressive soft-tissue cancer that rarely responds to chemotherapy, according to the SARC041 trial. Patients (n=108) in the phase IIII study had recurrent or metastatic dedifferentiated liposarcoma (DDLS) that had been treated with any number…
‘Immediately Practice-Changing’ Lung Cancer Trial in Curative Setting
Source link : https://newshealth.biz/health-news/immediately-practice-changing-lung-cancer-trial-in-curative-setting/ CHICAGO — The adjuvant treatment of RET fusion-positive non-small-cell lung cancer (NSCLC) following potentially curative surgery or radiotherapy has a new standard of care, researchers reported here. In a phase III study of patients who underwent definitive therapy for stage II-IIIA disease, event-free survival (EFS) at 2 years reached 92% with…
Top-risk prostate most cancers sufferers take pleasure in perioperative apalutamide treatment
Source link : https://health365.info/top-risk-prostate-most-cancers-sufferers-take-pleasure-in-perioperative-apalutamide-treatment/ Top-risk localized and in the community complicated prostate most cancers sufferers handled with apalutamide – a subsequent technology neoadjuvant androgen-receptor pathway inhibitor (ARPI) – plus hormone treatment earlier than and after prostate most cancers surgical treatment resulted in additional main pathologic responses and diminished the chance of metastasis or loss of…
Abemaciclib Slows Progression of Advanced Liposarcoma
Source link : https://newshealth.biz/health-news/abemaciclib-slows-progression-of-advanced-liposarcoma/ In a phase 3 trial of patients with dedifferentiated liposarcoma, the CDK4/6 inhibitor extended progression-free survival more than sixfold. Medscape Medical News Source link : https://www.medscape.com/viewarticle/abemaciclib-slows-progression-advanced-liposarcoma-2026a1000i2g?src=rss Author : Publish date : 2026-05-31 16:30:00 Copyright for syndicated content belongs to the linked Source. The post Abemaciclib Slows Progression of Advanced Liposarcoma first…
Predictive type is helping tailor PSMA remedy for prostate most cancers sufferers
Source link : https://health365.info/predictive-type-is-helping-tailor-psma-remedy-for-prostate-most-cancers-sufferers/ A brand new machine-learning way for prostate-specific membrane antigen (PSMA) remedy of metastatic castration-resistant prostate most cancers (mCRPC) may just estimate radiation dose to tumors and wholesome organs prior to remedy starts. The use of information already to be had from pre-therapy PET/CT scans, this novel prediction instrument may just assist…
Treatment Intensification Slows Metastatic Hormone-Sensitive Prostate Cancer
Source link : https://newshealth.biz/health-news/treatment-intensification-slows-metastatic-hormone-sensitive-prostate-cancer/ CHICAGO — Men with metastatic castration-sensitive prostate cancer (mCSPC) and DNA repair alterations had significantly longer progression-free survival (PFS) with a targeted drug plus an androgen receptor pathway inhibitor (ARPI), results from an international randomized trial showed. Radiographic (r)PFS at 3 years improved from 50% with enzalutamide (Xtandi) and placebo to…
Selpercatinib Cuts Recurrence Risk in Early RET+ NSCLC
Source link : https://newshealth.biz/health-news/selpercatinib-cuts-recurrence-risk-in-early-ret-nsclc/ In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC. Medscape Medical News Source link : https://www.medscape.com/viewarticle/selpercatinib-cuts-recurrence-risk-early-ret-non-small-cell-2026a1000i25?src=rss Author : Publish date : 2026-05-31 12:20:00 Copyright for syndicated content belongs to the linked Source. The post Selpercatinib…
‘Grand Slam’ in Pancreatic Cancer: Novel Pill Doubles Survival
Source link : https://newshealth.biz/health-news/grand-slam-in-pancreatic-cancer-novel-pill-doubles-survival/ CHICAGO — RASolute 302 trial results were hailed as a game-changing breakthrough in the treatment of pancreatic cancer. The phase III study showed that second-line daraxonrasib, an investigational oral RAS(ON) multi-selective inhibitor, doubled overall survival (OS) and progression-free survival (PFS) in patients with previously treated metastatic pancreatic ductal adenocarcinoma. In the…
Tackling Barriers to Lipid Management in Primary Care
Source link : https://newshealth.biz/health-news/tackling-barriers-to-lipid-management-in-primary-care/ Experts at the Primary Care Show identified the key barriers to lipid management — and what clinicians can do about them. Medscape News UK Source link : https://www.medscape.com/viewarticle/tackling-barriers-lipid-management-primary-care-2026a1000i26?src=rss Author : Publish date : 2026-05-31 12:38:00 Copyright for syndicated content belongs to the linked Source. The post Tackling Barriers to Lipid Management…
Why renaming my health condition could help other women
Source link : https://newshealth.biz/health-news/why-renaming-my-health-condition-could-help-other-women/ Rochelle Lewis is among more than 170 million woman globally to be diagnosed with PCOS. Source link : https://www.bbc.com/news/articles/cd9p50j3ljko?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-31 06:13:00 Copyright for syndicated content belongs to the linked Source. The post Why renaming my health condition could help other women first appeared on News Health.…
Drug Combo for Lung Cancer Beats Pembrolizumab in First-Line Trial
Source link : https://newshealth.biz/health-news/drug-combo-for-lung-cancer-beats-pembrolizumab-in-first-line-trial/ CHICAGO — Adding an investigational TROP2-targeted antibody-drug conjugate (ADC) to first-line immunotherapy for PD-L1-positive non-small cell lung cancer (NSCLC) reduced the risk of disease progression and may have improved survival as well, interim data from a Chinese phase III study indicated. Over a median follow-up of 10.5 months, sacituzumab tirumotecan (sac-TMT)…
Doctor Helps Woman Stop Blaming Herself and Accept Treatment
Source link : https://newshealth.biz/health-news/doctor-helps-woman-stop-blaming-herself-and-accept-treatment/ When an oncologist learns one patient’s story, everything shifts, including his approach to consultations. Medscape Medical News Source link : https://www.medscape.com/viewarticle/doctor-helps-woman-stop-blaming-herself-and-accept-treatment-2026a1000i20?src=rss Author : Publish date : 2026-05-30 20:22:00 Copyright for syndicated content belongs to the linked Source. The post Doctor Helps Woman Stop Blaming Herself and Accept Treatment first appeared on…
Tile-Based Radiation to Treat Large Brain Metastases?
Source link : https://newshealth.biz/health-news/tile-based-radiation-to-treat-large-brain-metastases/ The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions. Medscape Medical News Source link : https://www.medscape.com/viewarticle/tile-based-radiation-treat-large-brain-metastases-2026a1000i1s?src=rss Author : Publish date : 2026-05-30 12:01:00 Copyright for syndicated content belongs to the linked Source.…
Trump Order Tells CDC to Align With Study Calling for Fewer Childhood Vaccines
Source link : https://newshealth.biz/health-news/trump-order-tells-cdc-to-align-with-study-calling-for-fewer-childhood-vaccines/ President Donald Trump on Friday gave his endorsement to a January study by HHS that calls for cutting the number of vaccines recommended for every American child. An executive order from Trump directs federal agencies to align their policies behind the study, which recommended an overhaul long called for by HHS…
Weight Loss and Atrial Fibrillation; DAPT After Bypass Surgery
Source link : https://newshealth.biz/health-news/weight-loss-and-atrial-fibrillation-dapt-after-bypass-surgery/ TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical stories of the week. This week’s topics include duration of dual antiplatelet therapy…
Frontline Targeted Therapies Plus R-CHOP Boosts PFS in High-Risk B-Cell Lymphomas
Source link : https://newshealth.biz/health-news/frontline-targeted-therapies-plus-r-chop-boosts-pfs-in-high-risk-b-cell-lymphomas/ CHICAGO — Combining two targeted therapies with standard-of-care chemotherapy extended progression-free survival (PFS) in patients with newly diagnosed B-cell lymphomas, according to data from the frontMIND trial. In the phase III study, tafasitamab (Monjuvi) and lenalidomide (Revlimid) were added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) for frontline therapy in…
Endometrial Cancer Survivors Face Harder Path to IVF Success
Source link : https://newshealth.biz/health-news/endometrial-cancer-survivors-face-harder-path-to-ivf-success/ Patients in full remission from endometrial cancer who underwent fertility-preserving treatment before cancer treatment had less IVF success than matched controls. The question remains as to what exactly drives this difference in pregnancy outcomes. Authors noted that findings show preserving the uterus doesn’t necessarily preserve endometrial function, which should be considered…
You Can’t Blame a Payer for Trying
Source link : https://newshealth.biz/health-news/you-cant-blame-a-payer-for-trying/ I have spent 20 years working in out-of-network healthcare reimbursement. After reading the New York Times article “A $440,000 Breast Reduction? How Doctors Cash In on a Health Care Law,” I felt the payer’s use of the independent dispute resolution (IDR) process was not sufficiently scrutinized. The article details how the…
More Women With Breast Cancer Can Skip Axillary Dissection
Source link : https://newshealth.biz/health-news/more-women-with-breast-cancer-can-skip-axillary-dissection/ The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection. Medscape Medical News Source link : https://www.medscape.com/viewarticle/more-patients-breast-cancer-can-skip-axillary-dissection-2026a1000i1u?src=rss Author : Publish date : 2026-05-30 13:01:00 Copyright for syndicated content belongs to the…
Poop assessments and blood assessments sign up for colonoscopy as choices for colorectal most cancers screening
Source link : https://health365.info/poop-assessments-and-blood-assessments-sign-up-for-colonoscopy-as-choices-for-colorectal-most-cancers-screening/ It’s increasingly more not unusual to look headlines and social media conversations about the upward thrust in colorectal most cancers amongst more youthful adults. Actually, the rising occurrence of colorectal most cancers in other folks below age 50 helped force the American Most cancers Society’s 2018 choice to counsel decreasing the…